Acer Therapeutics Inc. Quarterly Cost of Revenue in USD for Q3 2023

Taxonomy & unit: us-gaap: USD
Description: The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary: Acer Therapeutics Inc. quarterly Cost of Revenue history and growth rate for Q3 2023.
Acer Therapeutics Inc. Cost of Revenue for the quarter ending September 30, 2023 was $83.8K.

Cost of Revenue, Quarterly (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2023		$83.8K			Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-20

* An asterisk sign (*) next to the value indicates that the value is likely invalid.